latest news in Pharmaceutical industry

Novartis Projects Steady Long-Term Sales Growth Powered by Upgraded Blockbuster Drugs

Novartis Projects Steady Long-Term Sales Growth Powered by Upgraded Blockbuster Drugs

Basel, Thursday, 19 November 2026.
Novartis projects 5% annual sales growth through 2031 and raised peak sales targets across key medicines, aiming to overcome the company’s largest patent cliff in history.